JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

Search

Omnicell Inc

Închisă

SectorSănătate

41.41 -3.29

Rezumat

Modificarea prețului

24h

Curent

Minim

41.04

Maxim

43.83

Indicatori cheie

By Trading Economics

Venit

-7.5M

-2M

Vânzări

3.4M

314M

P/E

Medie Sector

940.75

67.147

Marjă de profit

-0.645

Angajați

3,580

EBITDA

-9.8M

21M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+38.82% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-526M

1.7B

Deschiderea anterioară

44.7

Închiderea anterioară

41.41

Sentimentul știrilor

By Acuity

28%

72%

90 / 347 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Omnicell Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 apr. 2026, 23:08 UTC

Câștiguri

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 apr. 2026, 23:07 UTC

Câștiguri

Australia's Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 apr. 2026, 22:20 UTC

Câștiguri

Australia's ANZ Raises 1st Half Profit 9%, Warns of Coming Iran Impacts

30 apr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

30 apr. 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

30 apr. 2026, 23:47 UTC

Market Talk

Coles's Earnings Views Likely to Edge Down Despite Positives -- Market Talk

30 apr. 2026, 23:27 UTC

Market Talk

Liontown Lithium Recovery Expected to Improve -- Market Talk

30 apr. 2026, 23:22 UTC

Câștiguri

Apple's Incoming CEO John Ternus Makes Appearance as Company Bests Expectations -- Update

30 apr. 2026, 23:20 UTC

Market Talk

Wildcat Resources Stands Out Among Lithium Developers -- Market Talk

30 apr. 2026, 22:52 UTC

Câștiguri

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 apr. 2026, 22:33 UTC

Câștiguri

Zhejiang Expressway: Impairment Loss Weighed on Net >0576.HK

30 apr. 2026, 22:32 UTC

Câștiguri

Zhejiang Expressway 1Q Net CNY1.31B Vs. Net CNY1.48B >0576.HK

30 apr. 2026, 22:32 UTC

Câștiguri

Zhejiang Expressway 1Q Rev CNY5.32B Vs. CNY4.36B >0576.HK

30 apr. 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Also Reflects Time Needed to Implement Corporate Restructure For JV

30 apr. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Revised Timetable Reflects Time Needed to Get Regulatory Approvals

30 apr. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Now Expects Deal to Complete in 1H FY2027

30 apr. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Executes Key Formal Agreements With Posco on Stake Sale

30 apr. 2026, 22:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 apr. 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

30 apr. 2026, 22:11 UTC

Market Talk

Apple Says Demand for Lower-Cost Laptop is Off the Charts -- Market Talk

30 apr. 2026, 22:05 UTC

Câștiguri

Australia's ANZ Raises 1H Profit 9%, Warns of Coming Iran Impacts

30 apr. 2026, 21:57 UTC

Câștiguri

ANZ CEO: Increase in Collective Provisions Reflects Risk>ANZ.AU

30 apr. 2026, 21:56 UTC

Câștiguri

ANZ CEO: Minimal Impact on ANZ's Credit, Capital, Liquidity>ANZ.AU

30 apr. 2026, 21:56 UTC

Câștiguri

ANZ CEO: No Material Increase in New Cases of Household Hardship>ANZ.AU

30 apr. 2026, 21:55 UTC

Câștiguri

ANZ CEO: Households Entered Crisis With Generally Strong Balance Sheets>ANZ.AU

30 apr. 2026, 21:54 UTC

Câștiguri

ANZ CEO: No Material Change in Overall Corporate Borrowing Behavior >ANZ.AU

30 apr. 2026, 21:54 UTC

Câștiguri

ANZ CEO: Corporate Customers Have Been Building Capital, Liquidity Against Shocks>ANZ.AU

30 apr. 2026, 21:53 UTC

Câștiguri

ANZ CEO: Much of Iran Conflict's Potential Impact Remains Ahead>ANZ.AU

30 apr. 2026, 21:49 UTC

Câștiguri

ANZ Group 1H Total Operating Income A$11.20B Vs. A$10.995B>ANZ.AU

30 apr. 2026, 21:49 UTC

Câștiguri

ANZ Group 1H Customer Deposits A$770.7B Vs. A$756.6B>ANZ.AU

Comparație

Modificare preț

Omnicell Inc Așteptări

Obiectiv de preț

By TipRanks

38.82% sus

Prognoză pe 12 luni

Medie 59.83 USD  38.82%

Maxim 70 USD

Minim 49 USD

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOmnicell Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

7 ratings

6

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

24.23 / 30.44Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

90 / 347 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat